AllPennyStocks.com Media, Inc.

AllPennyStocks.com News: Products, Partnerships and Patents: Lexaria Biosciences Becoming a Force in Legal Cannabis Industry

 

Mississauga, ON -- (SBWIRE) -- 04/07/2017 -- AllPennyStocks.com Media, Inc. (http://www.AllPennyStocks.com/) announces its latest article titled "Products, Partnerships and Patents: Lexaria Biosciences Becoming a Force in Legal Cannabis Industry."

Companies mentioned in this article include Lexaria Bioscience Corp. (OTCQB:LXRP) (CSE:LXX).

Article Excerpt:

The legal marijuana space is an interesting proposition for early-stage investors, as there's no denying the relaxation of marijuana laws across the U.S. and Canada and forecasts for incredible growth that accompanies legalization of medical and/or recreational marijuana. Some market participants don't want to gamble on growers, choosing rather to focus on tech companies, like Lexaria Bioscience Corp. (OTCQB:LXRP) (CSE:LXX), due to a perceived better risk profile and less congested market segment than the land grab of wannabe growers.

A bioscience technology company, Lexaria is aiming to disrupt a U.S. market forecast to reach $50 billion in the next decade and a Canadian market expected to reach $4.5 billion by 2021 with its proprietary technology for improving delivery of bioactive compounds. The technology has many potential applications, including the cannabis sector, where Lexaria's lipophilic enhancement technology has been shown to improve taste (eliminates need for sugar-filled edibles) and enhance bioavailability of orally ingested cannabis components called cannabinoids.

The company uses long-chain fatty acids (sunflower oil, for example) to mask the unpleasant taste of active ingredients and allow them to bypass the liver for increased uptake into the body. Simply, better bioavailability means improved benefits of "the good stuff" in a product, or benefits equal to legacy products in smaller doses.

The full version of this article can be found at:
http://www.allpennystocks.com/aps_us/special-reports/740/products-partnerships-and-patents-lexaria-biosciences-becoming-a-force-in-legal-cannabis-industry.htm

About AllPennyStocks.com
AllPennyStocks.com is focused on the small-cap / penny stock market and has become a reputable name in the investment community. AllPennyStocks.com runs a Canadian and US site to provide investors in Canada as well as the United States with informative and unique content and information. AllPennyStocks.com runs daily technical penny stocks to watch, has a daily market write-up, provides company spotlights, runs unique most active pages strictly for penny stocks trading on the TSX, TSX Venture, NASDAQ and OTC BB, and much more information for the average investor.

AllPennyStocks.com also runs an email newsletter that aims to uncover stocks that are still under the radar of most investors. Criteria AllPennyStocks.com looks for includes strong revenues, a seasoned management, innovative business plans, among many others. AllPennyStocks.com also looks for companies that announce breaking news, recent 52-week highs/lows, technical breakouts, and other favorable corporate information.

Investors are encouraged to subscribe to the AllPennyStocks.com FREE e-mail newsletter and see what tens of thousands of other investors have already been receiving since 1999.

Investors can receive their free newsletter subscription by clicking here:
http://www.allpennystocks.com/aps_common/newsletter_free.asp

Contact:
AllPennyStocks.com Media, Inc.
Peter Szafranski -- President
Phone: 905-361-5680
E-Mail: peter@allpennystocks.com
Websites: http://www.allpennystocks.com / http://www.bullishinvestor.com

Note: AllPennyStocks.com has been compensated two thousand five hundred dollars from a third-party, Frontier Consulting, Ltd. for its efforts in presenting the LXRP profile on its web site and distributing it to its database of subscribers as well as other services.

For a complete disclaimer, investors are encouraged to click here: http://www.allpennystocks.com/SpotLight/3/Lexaria-Bioscience-Corp.htm